中文名 | WAY 316606 |
英文名 | WAY 316606 |
别名 | 方式 316606 化合物WAY 316606 SFRP-1抑制剂(WAY 316606) 5-(苯磺酰基)-N-(哌啶-4-基)-2-(三氟甲基)苯磺酰胺 |
英文别名 | CS-2786 WAY316606 WAY-316606 WAY 316606 5-(benzenesulfonyl)-N-piperidin-4-yl-2-(trifluoromethyl)benzenesulfonamide BenzenesulfonaMide, 5-(phenylsulfonyl)-N-4-piperidinyl-2-(trifluoroMethyl)- 5-(Phenylsulfonyl)-N-(piperidin-4-yl)-2-(trifluoromethyl)benzenesulfonamide |
CAS | 915759-45-4 |
EINECS | 1592732-453-0 |
化学式 | C18H19F3N2O4S2 |
分子量 | 448.4796696 |
密度 | 1.50±0.1 g/cm3(Predicted) |
沸点 | 601.1±65.0 °C(Predicted) |
酸度系数 | 8.76±0.20(Predicted) |
存储条件 | 2-8℃ |
体外研究 | The EC 50 of WAY-316606 for Wnt-Luciferase Activity from U2-OS Cells is 0.65 μM. WAY-316606 binds to secreted frizzled-related protein (sFRP)-1 inhibitor with a K D of 0.08 μM and inhibits sFRP-1 with an EC 50 of 0.65 μM. WAY-316606 also binds to sFRP-2, albeit over 10 times weaker with a K D of 1 μM. Using a fluorescence polarization binding assay that employs a fluorescent probe compound and purified human sFRP-1 protein in a competitive-binding format, the IC 50 for WAY-316606 is 0.5 μM. |
体内研究 | WAY-316606 increases bone formation when tested in a neonatal murine calvarial assay. WAY-316606 increases total bone area up to 60% in a dose-dependent manner with an EC 50 of about 1 nM. WAY-316606 has good aqueous solubility, moderate to low inhibition of cytochrome p450 isozymes (3A4, 2D6, 2C9) and good stability in rat and human liver microsomes (t 1/2 >60 min in each species). In female Sprague-Dawley rats, WAY-316606 exhibits high plasma clearance (77 mL/min/kg, greater than hepatic blood flow) following a single intravenous bolus dose (2 mg/kg), which results in a rapid decline of drug exposure in the plasma despite the route of administration. |
1mg | 5mg | 10mg | |
---|---|---|---|
1 mM | 2.23 ml | 11.149 ml | 22.298 ml |
5 mM | 0.446 ml | 2.23 ml | 4.46 ml |
10 mM | 0.223 ml | 1.115 ml | 2.23 ml |
5 mM | 0.045 ml | 0.223 ml | 0.446 ml |
微信搜索化工百科或扫描下方二维码,添加化工百科小程序,随时随地查信息!